Miras, Dionne Chixx .
HRN: 16-36-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/29/2022
12/05/2022
IVT
1,800mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes